139 related articles for article (PubMed ID: 6037073)
1. Potential carcinostatic agents. I. Derivatives and analogs of 1-(2-hydroxyethyl)-3-(4-tolyl)urea.
Nelson HG; Shelton FJ; Wetzel WH
J Med Chem; 1967 Jul; 10(4):735-6. PubMed ID: 6037073
[No Abstract] [Full Text] [Related]
2. Carcinostatic sulfonic acid esters of butyne- and butane-1,4-diols.
Earl RA; Harmon RE
J Med Chem; 1966 Sep; 9(5):776-8. PubMed ID: 5969056
[No Abstract] [Full Text] [Related]
3. The carcinostatic activity of thiosemicarbazones of formyl heteroaromatic compounds. 3. Primary correlation.
French FA; Blanz EJ
J Med Chem; 1966 Jul; 9(4):585-9. PubMed ID: 5968028
[No Abstract] [Full Text] [Related]
4. Synthesis of potential antineoplastic agents. XIV. Some 2-substituted 2,3-dihydro-1h-perimidines.
Wasulko W; Noble AC; Popp FD
J Med Chem; 1966 Jul; 9(4):599-601. PubMed ID: 4165378
[No Abstract] [Full Text] [Related]
5. Synthesis of potential antineoplastic agents. XV. Some l,4-bisamides of 1,2,3,4-tetrahydroquinoxaline.
Schuyler P; Popp FD; Noble AC; Alwani DW; Masters BR
J Med Chem; 1966 Sep; 9(5):704-7. PubMed ID: 6007964
[No Abstract] [Full Text] [Related]
6. 1,3,2-diazaphosphorine 2-oxides. 3. Preparation and biological evaluation of some 1,3-bis(aralkyl)-2-halo-1,3,2-diazaphosphorine 2-oxides and related compounds.
Billman JH; Meisenheimer JL; May RF
J Med Chem; 1966 Sep; 9(5):772-4. PubMed ID: 4291025
[No Abstract] [Full Text] [Related]
7. Derivatives of fluorene. XXII. Nitrogen mustards. II.
Fletcher TL; Wetzel WH; Namkung MJ
J Med Chem; 1966 Jul; 9(4):593-8. PubMed ID: 5968030
[No Abstract] [Full Text] [Related]
8. Potential carcinolytic agents. V. Enamine mustards.
Papanastassiou ZB; Bruni RJ; White E
J Med Chem; 1967 Jul; 10(4):701-6. PubMed ID: 6037064
[No Abstract] [Full Text] [Related]
9. The osmium tetroxide catalyzed hydroxylation of 1,4-dimethylenecyclohexanes.
Murphy JG
J Med Chem; 1966 Jan; 9(1):157-9. PubMed ID: 5958947
[No Abstract] [Full Text] [Related]
10. Synthesis and cytotoxicity of 4-aminobutyrophenone hydrochlorides and their substituted pyrimidinylhydrazones.
Cheng SS; Piantadosi C; Irvin JL
J Med Chem; 1966 Nov; 9(6):945-9. PubMed ID: 4961672
[No Abstract] [Full Text] [Related]
11. The carcinostatic activity of 5-hydroxy-2-formylpyridine thiosemicarbazone.
Blanz EJ; French FA
Cancer Res; 1968 Dec; 28(12):2419-22. PubMed ID: 5728150
[No Abstract] [Full Text] [Related]
12. Synthesis of potential antineoplastic agents. 35. Phosphorus-containing structural analogs of myleran.
Struck RF
J Med Chem; 1966 Mar; 9(2):231-4. PubMed ID: 5911803
[No Abstract] [Full Text] [Related]
13. The synthesis of potential anticancer agents. XXXVI. N-nitrosoureas. II. Haloalkyl derivatives.
Johnston TP; McCaleb GS; Opliger PS; Montgomery JA
J Med Chem; 1966 Nov; 9(6):892-911. PubMed ID: 5972051
[No Abstract] [Full Text] [Related]
14. 2-fluoroethylamines. II. Biological evaluation and synthesis.
Martinez AP; Lee WW; Goodman L
J Med Chem; 1965 Nov; 8(6):741-4. PubMed ID: 5885063
[No Abstract] [Full Text] [Related]
15. Carcinostatic activity of thiosemicarbazones of formyl heteroaromatic compounds. VII. 2-Formylpyridine derivatives bearing additional ring substituents.
Blanz EJ; French FA; DoAmaral JR; French DA
J Med Chem; 1970 Nov; 13(6):1124-30. PubMed ID: 5273758
[No Abstract] [Full Text] [Related]
16. The clinical impact of screening and other experimental tumor studies.
Johnson RK; Goldin A
Cancer Treat Rev; 1975 Mar; 2(1):1-31. PubMed ID: 1102083
[No Abstract] [Full Text] [Related]
17. Kethoxal bis(thiosemicarbazone). I. Effects against experimental tumors.
Mihich E; Nichol CA
Cancer Res; 1965 Oct; 25(9):1410-6. PubMed ID: 5217028
[No Abstract] [Full Text] [Related]
18. Carcinostatic activity of thiosemicarbazones of formyl heteroaromatic compounds. VI. 1-Formylisoquinoline derivatives bearing additional ring substituents, with notes on mechanism of action.
French FA; Blanz EJ; DoAmaral JR; French DA
J Med Chem; 1970 Nov; 13(6):1117-24. PubMed ID: 5273757
[No Abstract] [Full Text] [Related]
19. Potential antitumor agents. V. Bisquaternary salts.
Atwell GJ; Cain BF
J Med Chem; 1967 Jul; 10(4):706-13. PubMed ID: 6071972
[No Abstract] [Full Text] [Related]
20. Cyclic methyldopa analogs as potential antihypertensive and antineoplastic agents.
Burckhalter JH; Schmied G
J Pharm Sci; 1966 Apr; 55(4):443-5. PubMed ID: 5960301
[No Abstract] [Full Text] [Related]
[Next] [New Search]
